Unexpected Drug-Induced Liver Injury Associated With MenoFit: A Synbiotic Menopause Supplement.
| Autor: | Dadlani A; Section of Gastroenterology and Hepatology, Margaret M. and Albert B. Alkek Department of Medicine, Baylor College of Medicine, Houston, TX.; Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX., Anudu A; Section of Gastroenterology and Hepatology, Margaret M. and Albert B. Alkek Department of Medicine, Baylor College of Medicine, Houston, TX.; Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX., Marginean EC; Department of Pathology and Immunology, Baylor St. Luke's Hospital, Baylor College of Medicine, Houston, TX. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | ACG case reports journal [ACG Case Rep J] 2023 Sep 23; Vol. 10 (9), pp. e01153. Date of Electronic Publication: 2023 Sep 23 (Print Publication: 2023). |
| DOI: | 10.14309/crj.0000000000001153 |
| Abstrakt: | MenoFit is a widely available over-the-counter synbiotic supplement, which is marketed for use in relieving menopausal symptoms. So far, there is no published data on liver injury because of its use. We present the first reported case of MenoFit-induced liver injury in a patient who presented with 1 week of jaundice and abnormal liver biochemical tests in the absence of other risk factors and negative comprehensive workup for known etiologies of liver disease. (© 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|